GE last week paid Fonar $128.7 million for damages in the MRI patent infringement case Fonar is pursuing against the Milwaukee company. The payment does not mean the case is over for GE, however, as the company intends to continue its appeal of the case
GE last week paid Fonar $128.7 million for damages in the MRI patent infringement case Fonar is pursuing against the Milwaukee company. The payment does not mean the case is over for GE, however, as the company intends to continue its appeal of the case to the U.S. Supreme Court.
GE owed Fonar $103 million plus interest after losing a jury trial regarding the infringement of two Fonar patents, the multiangle oblique patent and the so-called basic patent (SCAN 6/11/97). GE has lost several appeals of the case, including one to the U.S. Court of Appeals, as well as a motion to have its payment of the damages postponed.
While GE made the payment as ordered by Judge Leonard Wexler, who presided over the case, GE still plans to appeal the case to the Supreme Court, a spokesperson said. If GE wins its appeal, Fonar will be required to return the money.
In other Fonar news, the Melville, NY, company said it has signed an agreement for sales of its Quad scanners with a medical equipment supplier based in the Far East. The first phase of the agreement calls for sales of five scanners in two years. If that phase is successfully completed, phase two will kick in, in which some Quad scanner assembly may occur in Asia. Before the second phase can begin, however, Fonar must receive orders for 40 Quad scanners, backed by a letter of credit for a minimum of $29 million. Fonar declined to name the company with whom it has signed the agreement.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.